Association of Low Leptin with Poor 3-Month Prognosis in Ischemic Stroke Patients with Type 2 Diabetes

Yi Zou,1 Ling Hu,1 Wenjun Zou,2 Honglin Li3 1Department of Endocrinology, The Third Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China; 2General Surgery, Nanchang Third Hospital, Nanchang, People’s Republic of China; 3Department of Biochemistry, Medi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zou Y, Hu L, Zou W, Li H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	leptin adipokine ischemic stroke type 2 diabetes prognosis Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/1629ce0e11b44c8aa56b6a3de7d49c55
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1629ce0e11b44c8aa56b6a3de7d49c55
record_format	dspace
spelling	oai:doaj.org-article:1629ce0e11b44c8aa56b6a3de7d49c552021-12-02T11:44:01ZAssociation of Low Leptin with Poor 3-Month Prognosis in Ischemic Stroke Patients with Type 2 Diabetes1178-1998https://doaj.org/article/1629ce0e11b44c8aa56b6a3de7d49c552020-12-01T00:00:00Zhttps://www.dovepress.com/association-of-low-leptin-with-poor-3-month-prognosis-in-ischemic-stro-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Yi Zou,1 Ling Hu,1 Wenjun Zou,2 Honglin Li3 1Department of Endocrinology, The Third Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China; 2General Surgery, Nanchang Third Hospital, Nanchang, People’s Republic of China; 3Department of Biochemistry, Medical College of Georgia, Augusta, GA, USACorrespondence: Ling HuDepartment of Endocrinology, The Third Affiliated Hospital of Nanchang University, No. 128 Xiangshan North Road, Nanchang 330000, Jiangxi Province, People’s Republic of ChinaTel +86 791-88862350Email hul@medmail.com.cnBackground: Leptin, an adipokine, has effects on the cardiovascular system with both protective and harmful role. This study aimed to assess the relationship between leptin and 3-month prognosis in ischemic stroke patients with type 2 diabetes.Patients and Methods: As a prospective single-center observational study, we collected consecutive first-ever acute ischemia stroke with type 2 diabetes mellitus from February 2019 to February 2020. Serum samples were obtained at admission, and leptin serum levels were tested by the ELISA method. Logistic regression models were used to assess leptin’s prognostic value to predict the functional outcome and mortality within three months.Results: Finally, two hundred and eleven patients were included, and the mean leptin serum level was 16.8 (SD. 6.9) ng/mL. At admission, 53.6% of those included patients (N=113) were defined as severe stroke (NIH Stroke Scale [NIHSS]> 5). In multivariable models adjusted for other factors, leptin levels< 11.6ng/mL (lowest quartile, Q1) related to severe stroke and the risk increased 175% (odds ratios [OR] =2.75; 95% confidence interval [CI]=2.13– 3.38; P=0.002). Serum leptin levels on admission in patients with poor outcomes and nonsurvivors were significantly reduced (P< 0.001 and P< 0.001). Leptin levels < 11.6ng/mL (lowest quartile, Q1) related to a higher risk of poor functional impairment (OR=5.13; 95% CI =3.25– 6.86; P< 0.001) and mortality (OR=3.19; 95% CI =2.03– 4.25; P< 0.001).Conclusion: The data shows that leptin serum level is a useful prognostic biomarker in ischemic stroke patients with type 2 diabetes, and this relationship is negative.Keywords: leptin, adipokine, ischemic stroke, type 2 diabetes, prognosisZou YHu LZou WLi HDove Medical Pressarticleleptinadipokineischemic stroketype 2 diabetesprognosisGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 15, Pp 2353-2361 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	leptin adipokine ischemic stroke type 2 diabetes prognosis Geriatrics RC952-954.6
spellingShingle	leptin adipokine ischemic stroke type 2 diabetes prognosis Geriatrics RC952-954.6 Zou Y Hu L Zou W Li H Association of Low Leptin with Poor 3-Month Prognosis in Ischemic Stroke Patients with Type 2 Diabetes
description	Yi Zou,1 Ling Hu,1 Wenjun Zou,2 Honglin Li3 1Department of Endocrinology, The Third Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China; 2General Surgery, Nanchang Third Hospital, Nanchang, People’s Republic of China; 3Department of Biochemistry, Medical College of Georgia, Augusta, GA, USACorrespondence: Ling HuDepartment of Endocrinology, The Third Affiliated Hospital of Nanchang University, No. 128 Xiangshan North Road, Nanchang 330000, Jiangxi Province, People’s Republic of ChinaTel +86 791-88862350Email hul@medmail.com.cnBackground: Leptin, an adipokine, has effects on the cardiovascular system with both protective and harmful role. This study aimed to assess the relationship between leptin and 3-month prognosis in ischemic stroke patients with type 2 diabetes.Patients and Methods: As a prospective single-center observational study, we collected consecutive first-ever acute ischemia stroke with type 2 diabetes mellitus from February 2019 to February 2020. Serum samples were obtained at admission, and leptin serum levels were tested by the ELISA method. Logistic regression models were used to assess leptin’s prognostic value to predict the functional outcome and mortality within three months.Results: Finally, two hundred and eleven patients were included, and the mean leptin serum level was 16.8 (SD. 6.9) ng/mL. At admission, 53.6% of those included patients (N=113) were defined as severe stroke (NIH Stroke Scale [NIHSS]> 5). In multivariable models adjusted for other factors, leptin levels< 11.6ng/mL (lowest quartile, Q1) related to severe stroke and the risk increased 175% (odds ratios [OR] =2.75; 95% confidence interval [CI]=2.13– 3.38; P=0.002). Serum leptin levels on admission in patients with poor outcomes and nonsurvivors were significantly reduced (P< 0.001 and P< 0.001). Leptin levels < 11.6ng/mL (lowest quartile, Q1) related to a higher risk of poor functional impairment (OR=5.13; 95% CI =3.25– 6.86; P< 0.001) and mortality (OR=3.19; 95% CI =2.03– 4.25; P< 0.001).Conclusion: The data shows that leptin serum level is a useful prognostic biomarker in ischemic stroke patients with type 2 diabetes, and this relationship is negative.Keywords: leptin, adipokine, ischemic stroke, type 2 diabetes, prognosis
format	article
author	Zou Y Hu L Zou W Li H
author_facet	Zou Y Hu L Zou W Li H
author_sort	Zou Y
title	Association of Low Leptin with Poor 3-Month Prognosis in Ischemic Stroke Patients with Type 2 Diabetes
title_short	Association of Low Leptin with Poor 3-Month Prognosis in Ischemic Stroke Patients with Type 2 Diabetes
title_full	Association of Low Leptin with Poor 3-Month Prognosis in Ischemic Stroke Patients with Type 2 Diabetes
title_fullStr	Association of Low Leptin with Poor 3-Month Prognosis in Ischemic Stroke Patients with Type 2 Diabetes
title_full_unstemmed	Association of Low Leptin with Poor 3-Month Prognosis in Ischemic Stroke Patients with Type 2 Diabetes
title_sort	association of low leptin with poor 3-month prognosis in ischemic stroke patients with type 2 diabetes
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/1629ce0e11b44c8aa56b6a3de7d49c55
work_keys_str_mv	AT zouy associationoflowleptinwithpoor3monthprognosisinischemicstrokepatientswithtype2diabetes AT hul associationoflowleptinwithpoor3monthprognosisinischemicstrokepatientswithtype2diabetes AT zouw associationoflowleptinwithpoor3monthprognosisinischemicstrokepatientswithtype2diabetes AT lih associationoflowleptinwithpoor3monthprognosisinischemicstrokepatientswithtype2diabetes
_version_	1718395267153133568

Association of Low Leptin with Poor 3-Month Prognosis in Ischemic Stroke Patients with Type 2 Diabetes

Ejemplares similares